CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Activity

11 hedge funds and large institutions have $5.23M invested in Cellectar Biosciences in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

Holders
11
Holders Change
+10
Holders Change %
+1,000%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AWMDMG
1
Austin W. Marxe & David M. Greenhouse
New York
$3.3M
2
CAM
2
Cormorant Asset Management
Massachusetts
$1.18M
3
SC
3
Sophrosyne Capital
New York
$389K
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$224K
5
BA
5
Bard Associates
Illinois
$95K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
AWMDMG
1
Austin W. Marxe & David M. Greenhouse
New York
$3.3M 2,208,368 +2,208,368 New
CAM
2
Cormorant Asset Management
Massachusetts
$1.18M 530,000 +530,000 New
SC
3
Sophrosyne Capital
New York
$389K 175,000 +175,000 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$224K 98,679 +98,679 New
BA
5
Bard Associates
Illinois
$95K 43,000 +20,077 +88%
KCM
6
Knoll Capital Management
Florida
$33K 14,634 +14,634 New
Morgan Stanley
7
Morgan Stanley
New York
$6K 2,569 +2,569 New
U
8
UBS
Switzerland
$6K 2,659 +2,659 New
SM
9
Sabby Management
Florida
$1.66K 730,609 +730,609 New
US Bancorp
10
US Bancorp
Minnesota
$0 150 +150 New
TRCT
11
Tower Research Capital (TRC)
New York
$0 191 +191 New